Proliferation tissue polypeptide antigen distinguishes malignant mucinous cystadenocarcinomas from benign cystic tumors and pseudocysts

American Journal of Surgery

Volumn 171, Issue 1, 1996, Pages 126-130

  Yang, Jane M ^a   Southern, James F ^a   Warshaw, Andrew L ^a   Lewandrowski, Kent B ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

CELL PROLIFERATION; CLINICAL ARTICLE; CONFERENCE PAPER; CYSTADENOCARCINOMA; DIAGNOSIS; GENE EXPRESSION; HUMAN; IMMUNOASSAY; PANCREAS CYST; PANCREAS PSEUDOCYST; PRIORITY JOURNAL;

ANTIGENS, NEOPLASM; CYSTADENOCARCINOMA, MUCINOUS; CYSTADENOCARCINOMA, SEROUS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PANCREATIC CYST; PANCREATIC NEOPLASMS; PANCREATIC PSEUDOCYST; PEPTIDES; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0030069043     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(99)80086-5     Document Type: Article

References (20)

1. Warshaw A, Compton C, Lewandrowski K, et al. Cystic tumors of the pancreas. New clinical, radiologic, and pathologic observations in 67 patients. Ann Surg. 1990;212:432-445.
2. Compagno J, Oertel J. Mucinous cystic neoplasms of the pancreas with overt and latent malignancy (cystadenocarcinoma and cystadenoma). A clinicopathologic study of 41 cases. Am J Clin Pathol. 1978;69:573-580.
3. Lewandrowski K, Southern J, Pins M, et al. Cyst fluid analysis in the differential diagnosis of pancreatic cysts: a comparison of pseudocysts, serous cystadenomas, mucinous cystic neoplasms, and mucinous cystadenocarcinoma. Ann Surg. 1993;217:41-47.
4. Warshaw A, Rutledge P. Cystic tumors mistaken for pancreatic pseudocysts. Ann Surg. 1987;205:393-398.
5. Lewandrowski K, Lee J, Southern J, et al. Cyst fluid analysis in the differential diagnosis of pancreatic cysts: a new approach to the preoperative assessment of pancreatic cystic lesions. Am J Roentgenol. 1995;164:815-819.
6. Lewandrowski K, Warshaw A, Compton C, et al. Variability of cyst fluid carcinoembryonic antigen level, fluid viscosity, amylase content, and cytologic findings among multiple loculi of a pancreatic mucinous cystic neoplasm. Am J Clin Pathol. 1993;100:425-427.
7. Pinto M, Meriano F. Diagnosis of cystic pancreatic lesions by cytologic examination and carcinoembryonic antigen and amylase levels of cyst contents. Acta Cytol. 1991;35:456-463.
8. Tatsuta M, Iishi H, Ichii M. Values of carcinoembryonic antigen, elastase-1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas. Cancer. 1986;57:1836-1839.
9. Yong W, Southern J, Pins M, et al. Cyst fluid NB/70K concentration and leukocyte esterase: two new markers for differentiating pancreatic serous tumors from pseudocysts. Pancreas. 1995;10: 342-346.
10. Rubin D, Warshaw A, Southern J, et al. Expression of CA 15.3 protein in the cyst contents distinguishes benign from malignant pancreatic mucinous cystic neoplasms. Surgery. 1992;115(1):52-55.
11. Alles A, Warshaw A, Southern J, et al. Expression of CA 72-4 (TAG-72) in the fluid contents of pancreatic cysts. A new marker to distinguish malignant pancreatic cystic tumors form benign neoplasms and pseudocysts. Ann Surg. 1994;219(92):131-134.
12. Nishida K, Shiga K, Kato K, et al. Two cases of pancreatic cystadenocarcinoma with elevated CA 19.9 levels in the cystic fluid in comparison with two cases of pancreatic cystadenoma. Hepatogastroenterology. 1989;36:442-445.
13. Nathrath W, Heidenkummer P, Bjorklund V, et al. Distribution of tissue polypeptide antigen (TPA) in normal human tissues: immunohistochemical study on unfixed, methanol-, ethanol-and formalin-fixed tissues. J. Histochem. Cytochem. 1985;33(2):99-109.
14. Basso D, Fabris C, Piccoli A. Serum tissue polypeptide antigen in pancreatic cancer and other gastrointestinal diseases. J Clin Pathol. 1989;42:555-557.
15. Panucci A, Fabris C, Del Favero G, et al. Tissue polypeptide antigen (TPA) in pancreatic cancer diagnosis. Br J Cancer. 1985;52: 801-803.
16. Meduri F, Doni M, Merenda R, et al. The role of the leukocyte adherence inhibition (LAI), CA 19-9, and tissue polypeptide antigen (TPA) tests in the diagnosis of pancreatic cancer. Cancer. 1989;64: 103-106.
17. Abbasciano V, Graziano L, Guerra S, et al. Coagulation disorders and tumor markers in the diagnosis of pancreatic cancer. Oncology. 1991;48:377-382.
18. Maulard C, Touber M, Chretien Y, et al. Serum tissue polypeptide antigen (S-TPA) in bladder cancer as a tumor marker. Cancer. 1994;73(2):394-398.
19. Kirby R, Lewandrowski K, Southern J, Warshaw A. Relation of epidermal growth factor receptor and estrogen receptor p52 protein to the malignant transformation of mucinous cystic neoplasms of the pancreas. Arch Surg. 1995;130:69-72.
20. Centeno B, Lewandrowski K, Warshaw A, et al. Cyst fluid cytologic analysis in the differential diagnosis of pancreatic cystic lesions. Am J Clin Pathol. 1994;101:483-487.